SURGICAL TREATMENT OF COLORECTAL CANCER IN SLOVENIA
Keywords:
colorectal cancer, surgical treatment, results, Slovenia, questionaireAbstract
Background. Colorectal cancer (CRC) is the third most common malignancy and the first most frequent cancer of the gastrointestinal tract occurring in Slovenia. In the Slovene Cancer Registry, there were 1022 new CRC cases and 598 deaths from CRC in 1998.
Methods. In 2000 a survey of patients with CRC was conducted in all surgical departments in Slovenia and the data were compared with those obtained in 1995.
Results. In year 2000 976 patients with CRC were admitted to all surgical departments in Slovenia: 346 (35.45%) out of 976 received treatment in Ljubljana (UMC 318, OI 28), 233 (23.87%) in two bigger regional hospitals and 397 (40.67%) in other 9 surgical units. In 1995 a total of 803 patients with CRC were treated in all surgical departments in Slovenia. The overall operability rate was 98% and resectability rate 81% and in 2000 97% and 83% respectively. Postoperative mortality rate in patients with resected CRC was 3.3% in 1995 and 4.1% in 2000.
Conclusions. In the last decade early results of surgical treatment of CRC patients (operability, resectability and postoperative mortality) are unchanged but late results (5-year survival, quality of life and paliative care) have improved
Downloads
References
Pompe-Kirn V, Zakotnik B, Volk N, Benulič T, Škrk J. Preživetje bolnikov z rakom prebavil v Sloveniji. Ljubljana: Onkološki inštitut, 1995.
Friedel HP. Epidemiologie des Kolorektalen Karzinoms In: Smola MG ed. ACO. Consensus-Bericht Kolonkarzinom. Arbeitsgemeinschaft fuer Chirurgische Onkologie der Oesterreichischen Gesellschaft fuer Chirurgie, 1995: 7–10.
Incidenca raka v Sloveniji. Poročila Registra raka za Slovenijo. Št. 25–41. Ljubljana: Onkološki inštitut. 1987–2002.
Repše S ed. Priporočila za celostno obravnavo bolnikov z rakom prebavil. Ljubljana: Ministrstvo za zdravstvo R Slovenije, 1997: 65–5.
Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38: 619–26.
Arbman G, Nilsson E, Stoergren-Fordell V, Sjoedahl R. Outcome of surgery for colorectal cancer in a defined population in Sweden from 1984 to 1996. Dis Colon Rectum 1995; 38: 645–50.
Maekelae JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. results of a prospective randomized triel. Arch Surg 1995; 130: 1062–7.
Platell C. A community-based hospital experience with colorectal cancer. Aust N Z J Surg 1997; 67: 420–3.
Singh KK, Barry MK, Ralston P, Henderson MA, McCormick JS, Walls AD, Auld CD. Audit of colorectal cancer surgery by non-specialist surgeons. Br J Surg 1997; 84: 343–7.
Kronberger L, Jatzko GR. Stadieneinteilung und Prognose des kolorektalen Karzinoms. In: Smola MG ed. ACO. Consensus-Bericht Kolonkarzinom. Arbeitsgemeinschaft fuer Chirurgische Onkologie der Oesterreichischen Gesellschaft fuer Chirurgie, 1995: 36–7.
Jatzko GR, Smola MG. Screening, Frueherkennung, Primaer- und Sekundaerpraevention. In: Smola MG ed. ACO. Consensus-Bericht Kolonkarzinom. Arbeitsgemeinschaft fuer Chirurgische Onkologie der Oesterreichischen Gesellschaft fuer Chirurgie, 1995: 15–7.
Samec HJ. Endoskopische Diagnostik und endoluminaler Ultraschall. In: Smola MG ed. ACO. Consensus-Bericht Kolonkarzinom. Arbeitsgemeinschaft fuer Chirurgische Onkologie der Oesterreichischen Gesellschaft fuer Chirurgie, 1995: 20–5.
Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth Ch. Multivisceral resection for locally advanced primary colon and rectal cancer. Ann Surg, 2002; 235: 217–25.
Pricolo VE, Potenti FM. Modern management of rectal cancer. Dig Surg 2001; 18: 1–20.
Glenny AM, Song F. Antimicrobial prophylaxis in colorectal surgery. Quality in Health Care 1999; 8: 132–6.
Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery: A national clinical guidline. Edinburgh: SIGN, 2000 (45).
Fleshman JW. The Effect of the Surgeon and the Pathologist on Patient Survival After resection of Colon and Rectal Cancer. Ann Surg 2002; 235: 464–5.
Martling A, Cedermark B, Johansson H, Rutquist LE, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. B J Surg 2002; 89: 1008–13.
Dowdall JF, Maguire D, McAnena OJ. Experience of surgery for rectal cancer with total mesorectal excision in general surgical practice. B J Surg 2002; 89: 1014–9.
Paty PB, Nash GM, Baron P et al. Long-term results of local excision for rectal cancer. Ann Surg 2002; 236: 522–30.
O’ Connell MJ, Laurie JA, Kahn M et al. Prospecttively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1999; 16: 295–300.
Vironen JH, Halme L, Saino P, Kylloenen LEJ, Scheinin T, Husa AI, Kellokupu IH. New approaches in the management of rectal carcinoma results in reduced local recurrence rate and improved survival. Eur J Surg 2002; 168: 158–64.
Delaney CP, Lavery IC, Brenner A, Hammel J, Senagore AJ, Noone RB, Fazio VW. Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg 2002; 236: 203–7.
Onaitis MW, Noone RB, Hartwig M et al. Neoadjuvant chemoradiation for rectal cancer: Analysis of a clinical outcomes from a 13-year institutional experience. Ann Surg 2001; 233: 778–85.
Repše S, Štor Z, Juvan R. Kirurgija raka debelega črevesa in danke v Sloveniji. In: Repše S ed. Kirurgija debelega črevesa in danke. Kirurška šola. Ljubljana, Kirurške klinike KC, 1996: 118–26.
Repše S. Kirurgija raka debelega črevesa in danke v Sloveniji. In: Komadina R ed. Zbornik predavanj III. kongres Združenja kirurgov Slovenije, Portorož, 22.–25. maj 2002. Ljubljana: Združenje kirurgov Slovenije, 139–40.
Downloads
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
